The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial
Latest Information Update: 15 Mar 2024
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Follitropin alfa (Primary) ; Ganirelix (Primary) ; Progesterone (Primary) ; Triptorelin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Acronyms INTENS-EQ trial
- 08 Mar 2024 Planned End Date changed from 1 Jun 2024 to 1 Jun 2026.
- 08 Mar 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2025.
- 16 Jul 2021 New trial record